
|Articles|September 1, 2003
- Volume 0 0
Learning Objectives
Advertisement
Learning Objectives
After reading these articles, the reader should be able to:
- Describe current and emerging pharmacologic options for lipid lowering therapy
- Explain how to intensify lipid-lowering therapy if necessary to achieve National Cholesterol Education Program goals
- Provide suggestions for effective patient counseling about lipid-lowering therapy and goals.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























